|
(ÁÖ)ÄÚ¸®¾Æ¹ÙÀÌ¿À¹Í½º |
¼¿ï °µ¿±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
»ý¸í°øÇÐ/¹ÙÀÌ¿À ¿µ¾÷ |
1³â¡è |
ä¿ë½Ã |
09.05 |
|
|
Çѱ¹MSD À¯ÇÑȸ»ç |
CRA ´Ù¼ö ä¿ë
¼¿ï Áß±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
ÀÓ»ó BD/RA/QA |
2³â¡è |
ä¿ë½Ã |
08.05 |
|
|
Çѿ츮D&C |
ÆòÅà ¼Ò¾Æ°ú ½Å±Ô¾à±¹ÀÚ¸® ¾à»ç´Ô ±¸ÇÕ´Ï´Ù.
°æ±â ÆòÅýà | Çз¹«°ü |
¾à»ç/ÇѾà»ç |
°æ·Â¹«°ü |
»ó½Ãä¿ë |
09.04 |
|
|
Çѱ¹MSD À¯ÇÑȸ»ç |
CRA 6¸í ä¿ë
¼¿ï ÀüÁö¿ª | ´ëÇÐ(4³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
1³â¡è |
ä¿ë½Ã |
10.04 |
|
|
Çѱ¹MSD À¯ÇÑȸ»ç |
Oncology MSL 2¸í ä¿ë
¼¿ï Áß±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
¾à»ç/ÇѾà»ç |
2³â¡è |
ä¿ë½Ã |
10.31 |
|
|
Çѱ¹MSD À¯ÇÑȸ»ç |
Çѱ¹MSD CRA ´Ù¼ö ä¿ë
¼¿ï Áß±¸ | ´ëÇÐ(2~3³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
2³â¡è |
ä¿ë½Ã |
09.04 |
|
|
Çѱ¹MSD À¯ÇÑȸ»ç |
Çѱ¹MSD ±¸¸ÅºÎ Procurement specialist ¸ðÁý
¼¿ï Áß±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
ÇϹݱ⠻ç¿ø¸ðÁý |
3³â¡è |
ä¿ë½Ã |
09.04 |
|
|
½Ã¹ÍÄÚ¸®¾Æ |
DMA II, Sr.DMA ä¿ë
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
STAT/DM |
2³â¡è |
ä¿ë½Ã |
11.11 |
|
|
ÄÉÀÌÆÊ |
ÄÉÀÌÆÊ ¹°·ùÁ÷ Á¤±ÔÁ÷¿ø ¸ðÁýÇÕ´Ï´Ù.
¼¿ï µ¿´ë¹®±¸ | Çз¹«°ü |
»ý»êÁö¿ø/¹°·ù/±¸¸Å |
°æ·Â¹«°ü |
ä¿ë½Ã |
11.21 |
|
|
¸®ÄÚ¸®ÁÖ½Äȸ»ç |
ÀÇÇÐÀü¹®ÀÚ·á Åë¹ø¿ª¸ðÁý(Áß±¹¾î)
¼¿ï ¼Ãʱ¸ | ´ëÇÐ(4³â) Á¹¾÷ |
¼ö½Ãä¿ë |
°æ·Â¹«°ü |
ä¿ë½Ã |
10.16 |
|
|
¸®ÄÚ¸®ÁÖ½Äȸ»ç |
ÈÀåÇ°, ÀǾà¿ÜÇ°(º¸Å彺,ÇÊ·¯) ¿µ¾÷»ç¿ø ¸ðÁýÇÕ´Ï´Ù.
¼¿ï ¼Ãʱ¸ | ´ëÇÐ(4³â) Á¹¾÷ |
°Ç°º¸Á¶½ÄÇ°/ÈÀåÇ°¿µ¾÷ |
3³â¡è |
ä¿ë½Ã |
10.16 |
|
|
Çѱ¹MSD À¯ÇÑȸ»ç |
Market access(Price&reimburse)specialist ¸ðÁý
¼¿ï Áß±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
±¤°í/È«º¸/PR/»çº¸ |
3³â¡è |
ä¿ë½Ã |
10.29 |
|
|
Çѱ¹MSD À¯ÇÑȸ»ç |
Oncology Pricing&Reimburse specialist¸ðÁý
¼¿ï Áß±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
°³¹ß/RA/´ë°ü |
3³â¡è |
ä¿ë½Ã |
11.15 |
|
|
(ÁÖ)ÄÚ¸®¾Æ¹ÙÀÌ¿À¹Í½º |
¿µ¾÷Áö¿ø¹× ±â¼ú¿µ¾÷Áö¿ø
¼¿ï ÀüÁö¿ª | ´ëÇÐ(4³â) Á¹¾÷ |
»ý¸í°øÇÐ/¹ÙÀÌ¿À ¿µ¾÷ |
½ÅÀÔ |
ä¿ë½Ã |
05.11 |
|
|
´ÙÀ̳볪(ÁÖ) |
´ÙÀ̳볪(ÁÖ) À繫ȸ°è ä¿ë °ø°í
¼¿ï ¸¶Æ÷±¸ | ´ëÇÐ(2~3³â) Á¹¾÷ |
À繫/ȸ°è/IR/ÀÚ±Ý/°¨»ç |
3³â¡è |
ä¿ë½Ã |
03.02 |
|